PrescriptionMedicines – Government Tightens Rules on Sale of Syrup-Based Drugs
PrescriptionMedicines – The Central Government has introduced a significant change in the way syrup-based medicines are sold across India. Under the latest regulatory amendment, consumers will no longer be able to purchase cough syrups and other syrup formulations directly from pharmacies without presenting a valid prescription issued by a registered medical practitioner.
Amendment to Long-Standing Drug Regulations
The decision comes after the Ministry of Health and Family Welfare formally revised provisions under the Drugs Rules, 1945. The amendment was notified through the Drugs (Fifth Amendment) Rules, 2026, and published in the Official Gazette on June 9.
According to the revised rules, syrup formulations have been removed from a category that previously allowed certain exemptions under existing drug regulations. As a result, these medicines will now be governed by stricter requirements related to their sale and distribution.
What Has Changed in Schedule K
The amendment specifically alters Schedule K of the Drugs Rules, 1945. This schedule outlines categories of medicines that are exempt from selected provisions of Chapter IV of the Drugs and Cosmetics Act, 1940, provided certain conditions are met.
Officials clarified that the word “Syrups” has been deleted from item number seven under serial number 13 of Schedule K. With this change taking effect, syrup-based medicines will no longer enjoy the exemptions that previously applied to them.
Public Consultation Conducted Before Final Decision
Before implementing the revised framework, the government released a draft notification on December 29, 2025. Stakeholders, industry representatives, healthcare professionals, and members of the public were invited to submit their views and recommendations regarding the proposed changes.
Authorities stated that all objections and suggestions received during the consultation period were examined before the final rules were approved and notified.
Expert Body Consulted During Rule-Making Process
The notification also highlighted that the amendment was introduced after consultation with the Drugs Technical Advisory Board, the country’s key technical body responsible for advising the government on matters related to pharmaceuticals and drug regulation.
The Centre exercised powers granted under Sections 12 and 33 of the Drugs and Cosmetics Act, 1940, while finalizing the amendment. The notification stated that the revised rules were framed following the prescribed legal process and expert consultation.
Impact on Consumers and Pharmacies
With the new provision now in force, pharmacies will be required to ensure that customers provide a doctor’s prescription before purchasing syrup medicines covered by the amended rule. The move is expected to strengthen oversight of medicine usage and improve compliance with regulatory standards governing pharmaceutical sales.
Consumers who previously obtained cough syrups and similar medicines over the counter may now need to consult healthcare professionals before making such purchases.
Regulatory Framework Remains Central to Drug Safety
The Drugs Rules, 1945, established under the Drugs and Cosmetics Act, 1940, serve as the foundation for regulating the manufacture, sale, storage, and distribution of medicines across India. The latest amendment reflects the government’s continuing efforts to update regulatory mechanisms in line with evolving healthcare and safety requirements.